Literature DB >> 18942870

Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens.

Manfred Wuhrer1, Leendert Porcelijn, Rick Kapur, Carolien A M Koeleman, André Deelder, Masja de Haas, Gestur Vidarsson.   

Abstract

Various biological activities of immunoglobulin G (IgG) including antibody-dependent cellular cytotoxicity (ADCC) are modulated by the structural features of the N-glycans in the Fc part. In this study, we describe a population of IgG1 alloantibodies which are formed during pregnancy against human platelet antigens (HPA) of the fetus, causing fetoneonatal alloimmune thrombocytopenia. By analyzing the Fc-glycosylation of the pathogenic, affinity-purified IgG1 alloantibodies at the glycopeptide level using mass spectrometry, we found markedly decreased levels of core-fucosylation as well as increased levels of galactosylation and sialylation as compared to glycosylation patterns of total serum IgG1 of the same patients. Because IgG1 Fc-core-fucosylation is known to influence ADCC activity, modulation of core-fucosylation may have a profound effect on disease severity and prognosis. Studies in large patient cohorts will have to be performed to establish such correlations. Moreover, experiments in animal models as well as in vitro immunological tests will be needed to unravel the mechanisms regulating IgG Fc glycosylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18942870     DOI: 10.1021/pr800651j

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  46 in total

Review 1.  The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.

Authors:  Sybille Böhm; Inessa Schwab; Anja Lux; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

Review 2.  IgG Fc Glycosylation in Human Immunity.

Authors:  Taia T Wang
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

Review 3.  IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease.

Authors:  Jing Xue; Li-Ping Zhu; Qiang Wei
Journal:  Glycoconj J       Date:  2013-06-20       Impact factor: 2.916

4.  Glycomic profiling of glycoproteins.

Authors:  Jarkko Räbinä
Journal:  Glycoconj J       Date:  2013-02       Impact factor: 2.916

Review 5.  Functional diversification of IgGs through Fc glycosylation.

Authors:  Taia T Wang; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

6.  Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.

Authors:  Claudia Ferrara; Sandra Grau; Christiane Jäger; Peter Sondermann; Peter Brünker; Inja Waldhauer; Michael Hennig; Armin Ruf; Arne Christian Rufer; Martine Stihle; Pablo Umaña; Jörg Benz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

7.  Fc-glycosylation of IgG1 is modulated by B-cell stimuli.

Authors:  Jun Wang; Crina I A Balog; Kathrin Stavenhagen; Carolien A M Koeleman; Hans Ulrich Scherer; Maurice H J Selman; André M Deelder; Tom W J Huizinga; René E M Toes; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

8.  Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity.

Authors:  Nadia Anikeeva; Maria Steblyanko; Svetlana Fayngerts; Natalya Kopylova; Deborah J Marshall; Gordon D Powers; Takami Sato; Kerry S Campbell; Yuri Sykulev
Journal:  Eur J Immunol       Date:  2014-06-05       Impact factor: 5.532

Review 9.  Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Authors:  Michaela Seeling; Christin Brückner; Falk Nimmerjahn
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

Review 10.  Analytical and Functional Aspects of Antibody Sialylation.

Authors:  Johannes Stadlmann; Martin Pabst; Friedrich Altmann
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.